Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) - A primary prevention strategy
The quality of life, in itself, in cancer patients or in osteoporotic individuals, without even considering the side effects of the medication in the first place, has a considerable negative impact on the clinical outcome. The Medication Related Osteonecrosis of the Jaw (MRONJ), in the maxillofacial...
Saved in:
Main Authors: | Abdulrhman Al Abdullateef (Author), Muhanad S. Alhareky (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
by: Yong-Dae Kwon, et al.
Published: (2016) -
Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies
by: Raed AlRowis, et al.
Published: (2022) -
Panoramic Radiography Features of Medication-Related Osteonecrosis of the Jaws (MRONJ)
by: Rossana Izzetti, et al.
Published: (2023) -
New groups of drugs suspected in the medication-related osteonecrosis of the jaws (MRONJ)
by: Mel Mupparapu, et al.
Published: (2017) -
Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ)
by: Ran Yan, et al.
Published: (2022)